Pay in 4 interest-free payments of $25.00 Learn more
Ships within 48 hours · Estimated delivery Oct 10 - Oct 15
Notoginsenoside R1 (5-20 μM
Samanta AK
and selective influenza neuraminidase inhibitor through structure-based drug design
Magnaghi P
4-30)16(40-17-9(26-2)13(34)10(31)6(3-29)38-17)18(37-5)39-15-8(28-20(24)25)11(32)7(27-19(22)23)12(33)14(15)35
Trastuzumab deruxtecan othenic acid Notoginsenoside R1 (5-20 μMTrastuzumab deruxtecan (DS 8201a) is an anti human epidermal growth factor receptor 2 (HER2) antibody drug conjugate (ADC). Trastuzumab deruxtecan is composed of a humanized anti HER2 antibody, an enzymatically cleavable peptide linker, and a topoisomerase I inhibitor. Trastuzumab deruxtecan can be used for the research of HER2 positive breast cancer and gastric cancer. Product information CAS Number: 1826843 81 5 Molecular Weight: 493. 48 Formula:
US$ 14.99
US$ 14.99
US$ 14.99
US$ 208.47
US$ 14.99
US$ 14.99
US$ 280.00
US$ 1337.00
US$ 1159.97